AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort

Recruitingn/aAges 18 Years - anyAllHospices Civils de Lyon
💬

In plain words

What the trial is, and whether it could suit you

The study aims to identify clinical profiles of long-COVID patients and correlate them with immunological and molecular data in order to identify prognostic biomarkers and potential therapeutic targets.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Documented SARS-CoV-2 infection * Persistent or complex post-COVID symptoms lasting more than 4 weeks or more than 3 months * Patient referred to the EPSILON pathway or to the post-COVID rehabilitation unit * Age ≥ 18 years * Non-institutionalized * Expected survival greater than 6 months Exclusion Criteria: * Refusal to participate or to share data * Uncontrolled comorbidities * Pregnant or breastfeeding women * Persons under legal protection or deprived of liberty * Not affiliated with the French national health insurance system
💊

What it tests

  • Blood sample collection
📍

Where

2 sites
Service Pneumologie aigue spécialisée et cancérologie thoracique
Pierre-Bénite, France
Hôpital Henry Gabrielle-HCL
Saint-Genis-Laval, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy